Gene: BCL3

602
BCL4|D19S37
B cell CLL/lymphoma 3
protein-coding
19q13.32
Ensembl:ENSG00000069399 MIM:109560 Vega:OTTHUMG00000151517 UniprotKB:P20749
NG_052809.1
PubMed
0   ANCO-SNPs
ND
3   
NA (AD)  NA (ND)   (Frontal_Cortex)
1.548e-1 (AD)  7.128e-1 (ND)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
SBNO20.876
TNFRSF10B0.871
NFKBIZ0.852
NFKB20.85
PNP0.849
PIM10.849
VASP0.847
LRRC320.845
SOCS30.845
CDK20.841

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
PPEF1-0.403
PTPRR-0.4
CASC15-0.4
AARD-0.398
SLC7A4-0.393
MARCH4-0.392
XKR4-0.392
NEUROD6-0.387
B3GALT2-0.379
SMIM18-0.376

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
C0264861,2,5,6-dibenzanthracene"1,2,5,6-dibenzanthracene results in increased expression of BCL3 mRNA"16269432
C0284741,4-bis(2-(3,5-dichloropyridyloxy))benzene"1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in decreased expression of BCL3 mRNA"28903501
C0284741,4-bis(2-(3,5-dichloropyridyloxy))benzene"1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of BCL3 mRNA"21354444
C0512461-methylanthracene[1-methylanthracene co-treated with fluoranthene] results in increased expression of BCL3 mRNA28329830
C0512461-methylanthraceneSB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of BCL3 mRNA]28329830
C5112952,2',4,4'-tetrabromodiphenyl ether"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of BCL3 mRNA"25614096
C0294972,3-bis(3'-hydroxybenzyl)butyrolactone"[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BCL3 mRNA"19167446
C0038982-anisidine2-anisidine affects the expression of BCL3 mRNA28089782
C5240423,5-bis(2-fluorobenzylidene)piperidin-4-one"3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of BCL3 mRNA]"23452621
C0343434-aminobenzhydrazide4-aminobenzhydrazide inhibits the reaction [hydroxyhydroquinone results in increased expression of BCL3 mRNA]24530881
C0275764-hydroxy-2-nonenal4-hydroxy-2-nonenal results in decreased expression of BCL3 mRNA19191707
C496492abrineabrine results in increased expression of BCL3 mRNA22595364
D000082AcetaminophenAcetaminophen results in decreased expression of BCL3 mRNA21420995|2906747
D000082AcetaminophenAcetaminophen affects the expression of BCL3 mRNA17562736
C016601afimoxifeneafimoxifene inhibits the reaction [Estrogens results in decreased expression of BCL3 mRNA]21233418
D016604Aflatoxin B1Aflatoxin B1 results in increased expression of BCL3 mRNA19770486
D000395Air Pollutants, Occupational"Air Pollutants, Occupational results in increased expression of BCL3 mRNA"23195993
D000638AmiodaroneAmiodarone results in increased expression of BCL3 mRNA22015988
C059765amphotericin B, deoxycholate drug combination"amphotericin B, deoxycholate drug combination results in increased expression of BCL3 mRNA"22863853
D018501Antirheumatic AgentsAntirheumatic Agents results in decreased expression of BCL3 mRNA24449571
C006632arsenic trioxide[arsenic trioxide co-treated with Bortezomib] results in decreased expression of BCL3 mRNA20471514
D017638Asbestos, Crocidolite"Asbestos, Crocidolite affects the expression of BCL3 mRNA"17331233
C030935benz(a)anthracene[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BCL3 mRNA27858113
C006703benzo(b)fluoranthene[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BCL3 mRNA27858113
D001564Benzo(a)pyreneBenzo(a)pyrene results in increased expression of BCL3 mRNA20106945|2231617
D001564Benzo(a)pyrene[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BCL3 mRNA27858113
D001564Benzo(a)pyreneBenzo(a)pyrene results in decreased expression of BCL3 mRNA19770486
D0151237,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of BCL3 mRNA"20018196|2038263
D004958EstradiolEstradiol results in decreased expression of BCL3 mRNA23373633
D004958EstradiolEstradiol inhibits the reaction [IL1B protein results in increased expression of BCL3 mRNA]12072388
C006780bisphenol Abisphenol A affects the methylation of BCL3 promoter27334623
C006780bisphenol Abisphenol A results in increased expression of BCL3 mRNA25181051
D000069286Bortezomib[arsenic trioxide co-treated with Bortezomib] results in decreased expression of BCL3 mRNA20471514
D000069286BortezomibBortezomib results in decreased expression of BCL3 mRNA20977926
C018475butyraldehydebutyraldehyde results in decreased expression of BCL3 mRNA26079696
D019256Cadmium ChlorideCadmium Chloride results in increased expression of BCL3 mRNA25993096
C004656chloroacetaldehydechloroacetaldehyde results in decreased expression of BCL3 mRNA25596134
C031180chrysene[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BCL3 mRNA27858113
D004002Clodronic AcidClodronic Acid results in decreased expression of BCL3 mRNA25596134
C023342closantelclosantel results in increased expression of BCL3 mRNA22015988
D019327Copper SulfateCopper Sulfate results in increased expression of BCL3 mRNA19549813
D003375Coumestrol"[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BCL3 mRNA"19167446
D003375Coumestrol[Coumestrol co-treated with resveratrol] results in decreased expression of BCL3 mRNA19167446
D003471CuprizoneCuprizone results in increased expression of BCL3 mRNA27523638
D003474CurcuminCurcumin inhibits the reaction [Oxygen deficiency results in increased expression of BCL3 mRNA]23452621
D003474CurcuminCurcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of BCL3 mRNA]18200517
D016572CyclosporineCyclosporine results in decreased expression of BCL3 mRNA25596134
D016572CyclosporineCyclosporine results in increased expression of BCL3 mRNA23958496
C010902decabromobiphenyl etherdecabromobiphenyl ether results in increased expression of BCL3 mRNA23914054
D003907DexamethasoneDexamethasone results in decreased expression of BCL3 mRNA25047013
D003907DexamethasoneDexamethasone results in decreased expression of BCL3 mRNA20032058
D003907DexamethasoneTestosterone inhibits the reaction [Dexamethasone results in decreased expression of BCL3 mRNA]20032058
D064730Dexrazoxane[Doxorubicin co-treated with Dexrazoxane] results in decreased expression of BCL3 mRNA26873546
D003976DiazinonDiazinon results in increased methylation of BCL3 gene22964155
D002945CisplatinCisplatin results in increased expression of BCL3 mRNA25596134
D002945CisplatinCisplatin results in increased expression of BCL3 mRNA24880025
D004008DiclofenacDiclofenac results in increased expression of BCL3 mRNA26934552
C000944dicrotophosdicrotophos results in increased expression of BCL3 mRNA28302478
D004026DieldrinDieldrin affects the expression of BCL3 mRNA22546817
D019422Dietary SucroseDietary Sucrose results in increased expression of BCL3 mRNA26033743
D004051Diethylhexyl PhthalateDiethylhexyl Phthalate results in increased expression of BCL3 mRNA19850644
D004051Diethylhexyl PhthalatePPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of BCL3 mRNA]19850644
C014476diethyl maleatediethyl maleate results in decreased expression of BCL3 mRNA25270620
D004317Doxorubicin[Doxorubicin co-treated with Dexrazoxane] results in decreased expression of BCL3 mRNA26873546
D004317DoxorubicinDoxorubicin results in increased expression of BCL3 mRNA26873546
C413879EKB 569EKB 569 results in decreased expression of BCL3 mRNA22242139
C045651epigallocatechin gallateepigallocatechin gallate results in increased expression of BCL3 mRNA22079256
C045651epigallocatechin gallate[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of BCL3 mRNA22079256
D004967Estrogensafimoxifene inhibits the reaction [Estrogens results in decreased expression of BCL3 mRNA]21233418
D004967EstrogensEstrogens results in decreased expression of BCL3 mRNA21233418
D004997Ethinyl Estradiol[Ethinyl Estradiol co-treated with ESR1 protein] inhibits the reaction [IL1B protein results in increased expression of BCL3 mRNA]12072388
D004997Ethinyl EstradiolEthinyl Estradiol inhibits the reaction [IL1B protein results in increased expression of BCL3 mRNA]12072388
D011345FenofibrateFenofibrate results in decreased expression of BCL3 mRNA25596134
C007738fluoranthene[1-methylanthracene co-treated with fluoranthene] results in increased expression of BCL3 mRNA28329830
C007738fluorantheneSB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of BCL3 mRNA]28329830
D005557FormaldehydeFormaldehyde results in decreased expression of BCL3 mRNA20655997
C039281furanfuran results in decreased expression of BCL3 mRNA25539665
D019833GenisteinGenistein inhibits the reaction [Oxygen deficiency results in increased expression of BCL3 mRNA]23452621
D019833GenisteinGenistein inhibits the reaction [IL1B protein results in increased expression of BCL3 mRNA]12072388
D005839GentamicinsGentamicins results in increased expression of BCL3 mRNA22061828
D005897GlafenineGlafenine results in increased expression of BCL3 mRNA24136188
D005978GlutathioneGlutathione deficiency results in decreased expression of BCL3 mRNA20621112
D017313FenretinideFenretinide results in increased expression of BCL3 mRNA28973697
D006861Hydrogen PeroxideHydrogen Peroxide affects the expression of BCL3 mRNA20044591
C013038hydroxyhydroquinone4-aminobenzhydrazide inhibits the reaction [hydroxyhydroquinone results in increased expression of BCL3 mRNA]24530881
C013038hydroxyhydroquinonehydroxyhydroquinone results in increased expression of BCL3 mRNA24530881
D015759Ionomycin[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of BCL3 mRNA25613284
D007501IronIron deficiency results in increased expression of BCL3 mRNA20368581
C561695(+)-JQ1 compound(+)-JQ1 compound inhibits the reaction [Lipopolysaccharides results in increased expression of BCL3 mRNA]25725100
C561695(+)-JQ1 compound(+)-JQ1 compound results in decreased expression of BCL3 mRNA24796395|2530787
D007854LeadLead affects the expression of BCL3 mRNA28903495
C045463leflunomideleflunomide results in increased expression of BCL3 mRNA28988120
C433788lipopolysaccharide, E. coli O26-B6"lipopolysaccharide, E. coli O26-B6 results in increased expression of BCL3 mRNA"23090859
C440499lipopolysaccharide, Escherichia coli O111 B4"lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of BCL3 mRNA"19264136
D008070Lipopolysaccharides(+)-JQ1 compound inhibits the reaction [Lipopolysaccharides results in increased expression of BCL3 mRNA]25725100
D008070LipopolysaccharidesLipopolysaccharides results in increased expression of BCL3 mRNA25725100
D008070LipopolysaccharidesLipopolysaccharides results in increased expression of BCL3 mRNA25890327
D008070LipopolysaccharidesLipopolysaccharides results in increased expression of BCL3 mRNA25613284
D018021Lithium ChlorideLithium Chloride results in increased expression of BCL3 mRNA23527032
D008727MethotrexateMethotrexate results in decreased expression of BCL3 mRNA24449571
D018817N-Methyl-3,4-methylenedioxyamphetamine"N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of BCL3 mRNA"26251327
D037742Nanotubes, Carbon"Nanotubes, Carbon analog results in increased expression of BCL3 mRNA"25554681|2562005
D037742Nanotubes, Carbon"Nanotubes, Carbon results in increased expression of BCL3 mRNA"25554681|2562005
D009532NickelNickel results in increased expression of BCL3 mRNA23195993|2476865
C022838nickel chloridenickel chloride affects the expression of BCL3 mRNA22546817
C030110oxaliplatin[oxaliplatin co-treated with Topotecan] results in increased expression of BCL3 mRNA25729387
D010100Oxygen"3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of BCL3 mRNA]"23452621
D010100OxygenCurcumin inhibits the reaction [Oxygen deficiency results in increased expression of BCL3 mRNA]23452621
D010100OxygenGenistein inhibits the reaction [Oxygen deficiency results in increased expression of BCL3 mRNA]23452621
D010100OxygenOxygen deficiency results in decreased expression of BCL3 mRNA25596134
D010100OxygenOxygen deficiency results in increased expression of BCL3 mRNA23452621
D010100OxygenPlant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of BCL3 mRNA]23452621
D010100Oxygenresveratrol inhibits the reaction [Oxygen deficiency results in increased expression of BCL3 mRNA]23452621
D010126Ozone[Ozone co-treated with NOTCH3 gene mutant form] affects the expression of BCL3 mRNA25658374
D052638Particulate MatterParticulate Matter results in increased expression of BCL3 mRNA21703343
C568608PCI 5002[PCI 5002 co-treated with Zinc] results in increased expression of BCL3 mRNA18593933
C006253pirinixic acidpirinixic acid results in decreased expression of BCL3 mRNA17426115
C006253pirinixic acidpirinixic acid results in increased expression of BCL3 mRNA18445702
D010936Plant ExtractsPlant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of BCL3 mRNA]23452621
C027373potassium chromate(VI)[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of BCL3 mRNA22079256
C027373potassium chromate(VI)potassium chromate(VI) results in decreased expression of BCL3 mRNA22079256
D011374ProgesteroneProgesterone affects the expression of BCL3 mRNA17251523
D011374ProgesteroneProgesterone results in increased expression of BCL3 mRNA19690047
D011441PropylthiouracilPropylthiouracil results in decreased expression of BCL3 mRNA24780913
C031280pyrazolepyrazole results in increased expression of BCL3 mRNA17945193
D020849Raloxifene HydrochlorideRaloxifene Hydrochloride inhibits the reaction [IL1B protein results in increased expression of BCL3 mRNA]12072388
D017382Reactive Oxygen SpeciesReactive Oxygen Species results in decreased expression of BCL3 mRNA25800948
C059514resveratrol[Coumestrol co-treated with resveratrol] results in decreased expression of BCL3 mRNA19167446
C059514resveratrolresveratrol inhibits the reaction [Oxygen deficiency results in increased expression of BCL3 mRNA]23452621
C059514resveratrol[resveratrol co-treated with Streptozocin] results in increased expression of BCL3 mRNA25905778
C093642SB 203580SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of BCL3 mRNA]28329830
D012643SeleniumSelenium results in increased expression of BCL3 mRNA19244175
D012822Silicon DioxideSilicon Dioxide analog results in decreased expression of BCL3 mRNA25895662
D012822Silicon DioxideSilicon Dioxide results in increased expression of BCL3 mRNA23221170
C017947sodium arseniteMIR2909 mRNA affects the reaction [sodium arsenite results in increased expression of BCL3 protein]23562784
C017947sodium arsenitesodium arsenite affects the localization of BCL3 protein20420878
C017947sodium arsenitesodium arsenite promotes the reaction [NFKB2 protein binds to BCL3 protein]20420878
C017947sodium arsenitesodium arsenite promotes the reaction [[NFKB2 protein binds to BCL3 protein] which results in increased expression of CCND1 protein]20420878
C017947sodium arsenitesodium arsenite results in increased expression of BCL3 protein20420878|2356278
C016104sodium bichromatesodium bichromate results in increased expression of BCL3 mRNA25993096
D053260SootSoot results in increased expression of BCL3 mRNA22461453|2655175
D013311Streptozocin[resveratrol co-treated with Streptozocin] results in increased expression of BCL3 mRNA25905778
D000952Antigens, Polyomavirus Transforming"Antigens, Polyomavirus Transforming results in increased expression of BCL3 mRNA"26680231
D014284TriiodothyronineTriiodothyronine results in increased expression of BCL3 mRNA22015988
D016559TacrolimusTacrolimus results in increased expression of BCL3 mRNA23958496
D013629TamoxifenTamoxifen affects the expression of BCL3 mRNA20937368
D013739TestosteroneTestosterone inhibits the reaction [Dexamethasone results in decreased expression of BCL3 mRNA]20032058
C020806tetrabromobisphenol Atetrabromobisphenol A results in increased expression of BCL3 mRNA22015988
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of BCL3 mRNA12377990|2010694
D013749Tetrachlorodibenzodioxin[Tetrachlorodibenzodioxin co-treated with TIPARP gene mutant form] results in decreased expression of BCL3 mRNA25975270
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of BCL3 mRNA18684927|2405805
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of BCL3 mRNA22298810
D013750TetrachloroethyleneTetrachloroethylene results in decreased expression of BCL3 mRNA28973375
D013755Tetradecanoylphorbol Acetate[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of BCL3 mRNA25613284
C009495titanium dioxidetitanium dioxide results in increased expression of BCL3 mRNA27760801
D014028Tobacco Smoke PollutionTobacco Smoke Pollution affects the expression of BCL3 mRNA20133372
D019772Topotecan[oxaliplatin co-treated with Topotecan] results in increased expression of BCL3 mRNA25729387
D014212TretinoinTretinoin results in increased expression of BCL3 mRNA17045167
D014302Trinitrobenzenesulfonic AcidCurcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of BCL3 mRNA]18200517
D014302Trinitrobenzenesulfonic AcidTrinitrobenzenesulfonic Acid results in increased expression of BCL3 mRNA18200517
C013320tris(2-butoxyethyl) phosphatetris(2-butoxyethyl) phosphate affects the expression of BCL3 mRNA29024780
D014415TunicamycinTunicamycin results in increased expression of BCL3 mRNA17127020
D014520UrethaneUrethane results in decreased expression of BCL3 mRNA28818685
D014635Valproic AcidValproic Acid results in decreased expression of BCL3 mRNA29154799
D014635Valproic AcidValproic Acid results in increased methylation of BCL3 gene29154799
C029297vinylidene chloridevinylidene chloride results in increased expression of BCL3 mRNA26682919
C111237vorinostatvorinostat results in decreased expression of BCL3 mRNA22083351
D015032Zinc[PCI 5002 co-treated with Zinc] results in increased expression of BCL3 mRNA18593933

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0003677DNA binding-IEA-  
GO:0003700DNA-binding transcription factor activity-IEA-  
GO:0005515protein binding-IPI10362352  16099425  16280327  16306601  21988832  
GO:0008134transcription factor binding-IPI8196632  11387332  16108830  16306601  
GO:0030674protein binding, bridging-TAS16306601  
GO ID GO Term Qualifier Evidence PubMed
GO:0000060protein import into nucleus, translocation-IMP16280327  
GO:0002268follicular dendritic cell differentiation-IEA-  
GO:0002315marginal zone B cell differentiation-IEA-  
GO:0002455humoral immune response mediated by circulating immunoglobulin-IEA-  
GO:0002467germinal center formation-IEA-  
GO:0006351transcription, DNA-templated-IDA16306601  
GO:0006974cellular response to DNA damage stimulus-IDA16384933  
GO:0007249I-kappaB kinase/NF-kappaB signaling-IDA8196632  
GO:0009615response to virus-IDA16306601  
GO:0010225response to UV-C-IDA16384933  
GO:0019730antimicrobial humoral response-IEA-  
GO:0030198extracellular matrix organization-IEA-  
GO:0030330DNA damage response, signal transduction by p53 class mediator-IMP16384933  
GO:0032729positive regulation of interferon-gamma production-IEA-  
GO:0042088T-helper 1 type immune response-IEA-  
GO:0042536negative regulation of tumor necrosis factor biosynthetic process-IEA-  
GO:0042742defense response to bacterium-IEA-  
GO:0042771intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator-IMP16384933  
GO:0042832defense response to protozoan-IEA-  
GO:0042981regulation of apoptotic process-IDA16732314  
GO:0043066negative regulation of apoptotic process-IDA16384933  
GO:0045064T-helper 2 cell differentiation-IEA-  
GO:0045082positive regulation of interleukin-10 biosynthetic process-IEA-  
GO:0045415negative regulation of interleukin-8 biosynthetic process-IMP16306601  
GO:0045727positive regulation of translation-IMP16384933  
GO:0045892negative regulation of transcription, DNA-templated-IDA16306601  
GO:0045893positive regulation of transcription, DNA-templated-IDA16384933  
GO:0045944positive regulation of transcription by RNA polymerase II-IEA-  
GO:0046426negative regulation of JAK-STAT cascade-IMP16306601  
GO:0048536spleen development-IEA-  
GO:0051101regulation of DNA binding-IEP9407099  
GO:0051457maintenance of protein location in nucleus-NAS8196632  
GO:1901222regulation of NIK/NF-kappaB signaling-IEP8196632  
GO ID GO Term Qualifier Evidence PubMed
GO:0005634nucleus-IDA8196632  16280327  16306601  
GO:0005654nucleoplasm-IDA-  
GO:0005737cytoplasm-IDA11387332  
GO:0005829cytosol-IDA-  
GO:0005886plasma membrane-IDA-  
GO:0030496midbody-IDA-  
GO:0032991protein-containing complex-IDA16280327  
GO:0032996Bcl3-Bcl10 complex-IDA16280327  
GO:0033257Bcl3/NF-kappaB2 complex-IDA9407099  
GO:0043231intracellular membrane-bounded organelle-IDA-  
GO:0048471perinuclear region of cytoplasm-IEA-  
KEGG ID KEGG Term
Reactome ID Reactome Term Evidence

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
11454503A case-control study of nonsyndromic oral clefts in Maryland. (2001 Aug)Beaty THAnn Epidemiol
9415696Application of transmission disequilibrium tests to nonsyndromic oral clefts: including candidate genes and environmental exposures in the models. (1997 Dec 19)Maestri NEAm J Med Genet
27824951Epigenetic Signatures at AQP3 and SOCS3 Engage in Low-Grade Inflammation across Different Tissues. (2016)Marzi CPLoS One